I-Mab - ADR

NASDAQ:IMAB   3:59:48 PM EDT
59.00
+0.15 (+0.26%)
Products

Morphosys, I-Mab Gets FDA Clearance Of Ind Application For Mor210/Tj210 In Patients With Advanced Cancer

Published: 09/17/2020 22:49 GMT
I-Mab - ADR (IMAB) - Morphosys and I-mab Announce FDA Clearance of Ind Application for Mor210/tj210 in Patients With Advanced Cancer.
I-mab - Phase 1 Clinical Study Expected to Start in Q4 2020.